Hereditary Breast and Ovarian Cancer / BRCA1 and BRCA2 Genes

✦ BRCA1 – pathogenic mutations are associated with a higher risk of ovarian cancer and a greater frequency of more aggressive forms of breast cancer that do not respond to conventional hormonal therapies.

✦ BRCA2 – pathogenic mutations are associated with an increased risk of male breast cancer and prostate cancer.

✦ In many BRCA-associated ovarian cancers, the earliest tumor-related changes occur in the fallopian tubes rather than in the ovaries themselves.

✦ Some tumors with BRCA mutations may respond better to treatments that target DNA, as cancer cells already have impaired DNA repair mechanisms.

🩸 The test is performed using a venous blood sample collected by venipuncture. The sample is processed in the laboratory to analyze the genetic material and identify the mutations covered by the test.

🧬 The test is available at every INVITRO Diagnostics branch.

For more information about the test and the promotional offer, visit:
https://www.invitro.md/en/services/brca1brca2-risc-ereditar-de-cancer-mamar-si-ovarian

For information about the test: ↓

🤳 InvitroZen App
💬 078 903 999 – message or call